UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): March 2, 2011
SAVIENT PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 0-15313 | 13-3033811 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
| One Tower Center East Brunswick, New Jersey |
08816 | |||
| (Address of principal executive offices) | (Zip Code) | |||
Registrant’s telephone number, including area code: (732) 418-9300
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 8.01. | Other Events. |
On March 2, 2011, Savient Pharmaceuticals, Inc. received notice from the Centers for Medicare and Medicaid Services that, effective April 1, 2011, a temporary “C-code” has been assigned to Krystexxa(R) (pegloticase), a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in patients refractory to conventional therapy.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: March 2, 2011 | Savient Pharmaceuticals, Inc. (Registrant) | |||
| By: | /s/ Philip K. Yachmetz | |||
| Name: | Philip K. Yachmetz | |||
| Title: | SVP, General Counsel | |||